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Abstract
Background: The aim of this study was to assess the effectiveness of homeopathy compared to conventional treatment
in acute respiratory and ear complaints in a primary care setting.
Methods: The study was designed as an international, multi-centre, comparative cohort study of non-randomised
design. Patients, presenting themselves with at least one chief complaint: acute (≤ 7 days) runny nose, sore throat, ear
pain, sinus pain or cough, were recruited at 57 primary care practices in Austria (8), Germany (8), the Netherlands (7),
Russia (6), Spain (6), Ukraine (4), United Kingdom (10) and the USA (8) and given either homeopathic or conventional
treatment. Therapy outcome was measured by using the response rate, defined as the proportion of patients
experiencing 'complete recovery' or 'major improvement' in each treatment group. The primary outcome criterion was
the response rate after 14 days of therapy.
Results: Data of 1,577 patients were evaluated in the full analysis set of which 857 received homeopathic (H) and 720
conventional (C) treatment. The majority of patients in both groups reported their outcome after 14 days of treatment
as complete recovery or major improvement (H: 86.9%; C: 86.0%; p = 0.0003 for non-inferiority testing). In the per-
protocol set (H: 576 and C: 540 patients) similar results were obtained (H: 87.7%; C: 86.9%; p = 0.0019). Further
subgroup analysis of the full analysis set showed no differences of response rates after 14 days in children (H: 88.5%; C:
84.5%) and adults (H: 85.6%; C: 86.6%). The unadjusted odds ratio (OR) of the primary outcome criterion was 1.40
(0.89–2.22) in children and 0.92 (0.63–1.34) in adults. Adjustments for demographic differences at baseline did not
significantly alter the OR. The response rates after 7 and 28 days also showed no significant differences between both
treatment groups. However, onset of improvement within the first 7 days after treatment was significantly faster upon
homeopathic treatment both in children (p = 0.0488) and adults (p = 0.0001). Adverse drug reactions occurred more
frequently in adults of the conventional group than in the homeopathic group (C: 7.6%; H: 3.1%, p = 0.0032), whereas in
children the occurrence of adverse drug reactions was not significantly different (H: 2.0%; C: 2.4%, p = 0.7838).
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Conclusion: In primary care, homeopathic treatment for acute respiratory and ear complaints was not inferior to
conventional treatment.
Background
The evidence base for complementary and alternative
medicine (CAM) in general is limited and there is cer-
tainly a need for more research in areas such as homeop-
athy [1]. Objective data collection and evaluation is
needed to assist physicians in patient care and advance the
quality of medical practice [2]. Clinical trials, especially
randomised controlled trials (RCTs), are generally
accepted as producing the highest level of evidence for
medical interventions. Driven by the discovery of new
pharmaceutical substances, demands from regulatory
authorities for clinical data and the need of physicians for
evidence based treatment strategies, the methodology of
RCTs became the subject of research itself. Within this
context, the strengths and weaknesses of such trials have
been debated [3]. Placebo-controlled RCTs are indispen-
sable for the development of pharmaceutical agents with
unknown efficacy and safety profiles. Their limitations
result from highly standardized study protocols and
patient populations, which may create artificial situations
that differ from daily practice. Moreover, even the fact that
patients are enrolled into a placebo-controlled clinical
trial will influence treatment outcome, sometimes leading
to high placebo or low verum response rates [4]. Conse-
quently, more practice-based studies have been developed
such as pragmatic RCT's or non-randomised cohort stud-
ies. Especially non-interventional outcomes studies have
only few inclusion and exclusion criteria. Therefore they
may provide information about a broad and heteroge-
nous patient population thus resulting in high external
validity for daily medical practice. However, the fact that
patients are not randomly assigned to treatments in such
outcome studies may lead to baseline differences between
groups and makes the interpretation of the results more
susceptible to bias. This disadvantage may be overcome,
at least in part, by the application of statistical methods to
control for baseline differences between treatment groups.
Apart from the ongoing discussion about clinical evi-
dence, complementary therapies are well integrated into
primary care in most Western countries. Among these,
homeopathy is the most frequently used form in various
acute and chronic conditions [5-9]. The value of homeop-
athy in chronic conditions has been demonstrated in sev-
eral studies. A comprehensive analysis of outcome and
cost-effectiveness showed that chronically ill patients had
a better overall outcome with homeopathic than with
conventional care [10]. Another large-scale observational
study showed a positive impact of homeopathy on the
health status in a substantial proportion of patients suffer-
ing from a wide range of different chronic diseases [11].
To our knowledge, no large comparative cohort studies
have been performed to investigate the outcome of home-
opathic treatment for acute illnesses. Results of the first
phase of this study, the International Integrative Primary
Care Outcomes Study 1 (IIPCOS-1), suggest that homeo-
pathic treatment is at least as effective as conventional
treatment for acute complaints of the upper and lower res-
piratory tract [12]. The aim of the present study, IIPCOS-
2, was to evaluate on an international basis and in a large
sample size if homeopathic treatment is non-inferior to
conventional treatment in patients with acute respiratory
and ear complaints.
Methods
Study design
IIPCOS-2 is an international, multi-centre, comparative
cohort study of non-randomised design, which was con-
ducted between October 1998 and April 2000. Patients
suffering from acute respiratory and ear complaints were
recruited by physicians in 57 primary care practices in
Austria (8), Germany (8), the Netherlands (7), Russia (6),
Spain (6), Ukraine (4), United Kingdom (10) and USA
(8). The physicians belonged to 3 different groups: pro-
viding homeopathic treatment only (22), providing either
homeopathic or conventional treatment (9), and provid-
ing conventional treatment only (12). The physicians,
prescribing primarily homeopathic single remedies, had
in addition to their conventional medical qualifications,
graduated from a homeopathic training program and at
least 5 years experience using homeopathy in their medi-
cal practice. The protocol was approved by the Interna-
tional Ethics Committee in Freiburg, Germany. The study
was conducted in accordance with the declaration of Hel-
sinki, Good Clinical Practice (GCP) guidelines and
national legal requirements.
Patients
Patients older than one month, presenting themselves
with at least one of five chief complaints (runny nose, sore
throat, ear pain, sinus pain or cough), and onset of symp-
toms not more than 7 days before, were eligible to partic-
ipate. Each chief complaint comprised of 5 to 9 individual
symptoms, which were rated by the physicians with scores
from 0 – not present to 4 – very severe. The mean score for
each chief complaint was used to measure severity at base-
line. Patients meeting the inclusion criteria, respectively in
case of children their parents/legal guardians, were
informed by the physician about the nature of the study.
Prior to enrolment into the trial each patient/parent hadBMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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to provide written informed consent to participate. Exclu-
sion criteria were among others severe mental impair-
ment, severe chronic diseases such as spinal cord injuries
and alcohol or drug abuse. At centres providing both ther-
apies (mixed centres) the treatment was chosen by the
physicians and/or following the patients' preference.
Study protocol
During the initial patient contact the physician docu-
mented the onset of chief complaint, severity of symp-
toms, clinical diagnosis, concomitant medical problems
and medication and primary treatment prescribed.
Patients completed a questionnaire asking for demo-
graphic and health-related information. Additionally
some general questions addressed the patients' willing-
ness to pay, patient confidence in health care provider and
therapy, treatment preference, willingness to be rand-
omized (at mixed centres only) etc. The patient follow-up
was carried out by telephone 7, 14 and 28 days after the
initial contact. Independent external study collaborators
performed the calls. According to the study protocol they
were blinded for the patient's treatment. The following
parameters were documented: severity of complaint-
related symptoms, time until occurrence of first improve-
ment, therapy outcome (assessed with complete recovery,
major improvement, slight improvement, no change or deterio-
ration), patient's satisfaction with the treatment (very satis-
fied, satisfied, neutral, dissatisfied or very dissatisfied) and
general health condition. In case any adverse events had
occurred, the physician was informed in order to collect
more information and medically assess the case.
The response rates were defined as the proportion of
patients assessing themselves as 'completely recovered' or
'major improved' after 7, 14 and 28 days of treatment. The
main outcome criterion was the response rate after 14
days. Other outcome criteria were the response rates after
7 and 28 days, time to onset of first improvement
(patients' assessments after how many days they had expe-
rienced a first improvement), patient satisfaction with
treatment and health care provider and the occurrence of
adverse events. Adverse events were coded by using the
WHO-ART terminology.
A total of 72 selected homeopathic medications in poten-
cies of 12C and higher (manufactured according to the
German Homeopathic Pharmacopoeia), were given to the
physicians as the basic set of study medication. Neverthe-
less, the physicians were free to prescribe any other rem-
edy, any other potency or dosage form. Conventional
treatment, registered in each participating country, was
prescribed by the investigator and picked from a phar-
macy.
Data collection and monitoring
Data were collected with a validated remote data entry sys-
tem that was accessed via the Internet. The physicians
entered their data online into electronic case report forms.
The remote data entry system checked each entry for com-
pleteness and consistency. It recorded all data values with
date and time of entry as well as all changes in the data-
base in an audit trail. Access to the database was protected
by password identification. Each user had a unique pass-
word that was provided in a sealed envelope. After enter-
ing was completed, data were transferred via Internet to
the data collection centre at the former Institute for
Numerical Statistics (IFNS, acquired by Omnicare Inc. in
1999) in Cologne, Germany. Monitoring was performed
adherent to GCP-guidelines by an independent clinical
monitor. Monitoring visits took place at least twice in
order to inspect the course of the trial and to carry out
source data verification. A data review tool enabled the
monitor to identify missing data values, data values devi-
ating from the normal range and among other things, data
needing source verification.
Statistical methods
Data analysis was conducted by ClinResearch, Cologne,
Germany, using the statistical software package SAS 9.1.3
under Windows XP Professional. The study was designed
to confirm non-inferiority of the primary outcome crite-
rion in the total patient population after homeopathic
treatment in comparison to conventional treatment, using
the one-sided equivalence test at the 2.5% significance
level. The non-inferiority margin was defined by 5%-
points. Subgroup analyses were performed on age groups
(children: < 18 years; adults: ≥ 18 years) with respect to
demographic data, response rates, patient satisfaction and
other outcome criteria using the Chi-square test, Fisher's
exact test and Wilcoxon's rank sum test. The treatment
groups were checked for baseline comparability and logis-
tic regression analysis was performed to control for base-
line differences. The primary and secondary outcome
criteria were analysed on the full-set population, compris-
ing all patients who received at least one dose of investi-
gational medication and having at least one follow-up
contact. Missing data in case of patient withdrawals from
the trial were replaced by applying the last observation
carried forward (LOCF) principle. A secondary analysis
was performed on the per-protocol set population, com-
prising all patients with follow-up data on day 14.
Results
Patients
A total of 2,055 patients suffering from at least one chief
complaint (acute runny nose, sore throat, ear pain, sinus
pain or cough) were enrolled in the study and given either
homeopathic (H: n = 1,220) or conventional treatment
(C: n = 829) (Figure 1). Six patients did not receive anyBMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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treatment and were excluded from further analysis. All
patients from the USA and Spain (H: n = 216; C: n = 29)
were excluded since telephone interviews were not per-
formed according to the study protocol. For another 227
patients no follow-up data were available because either
interviews could not be carried out or the patient with-
drew from the study. Data of 1577 patients with at least
one follow-up contact were evaluated (full-set analysis),
857 patients in the homeopathy group and 720 patients
in the conventional treatment group. For 1116 patients
(H: n = 576; C: n = 540) follow-up data on day 14 were
documented, being the per-protocol set (Figure 1).
Upon enrolment in the study, patients, or the patients'
legal guardians were asked for their treatment preference.
In the homeopathy group, 81% of patients had a prefer-
ence for homeopathy, 18% had no treatment preference.
In the conventional group, 55% of the patients' preferred
conventional treatment, 2% homeopathy and 43% had
no treatment preference. Patients at mixed centres were
additionally asked whether they would agree to be rand-
omized if the choice of treatment was made randomly.
With 68.1%, the majority of patients in the homeopathy
group refused to be randomized, 30.6% had no problem
with randomisation and in 1.3% no remark was given. In
the conventional group willingness and unwillingness to
be randomized were equally distributed (51.9% yes,
47.9% no, 0.1% no remark).
Baseline characteristics
Demographic data of children (< 18 years of age) and
adults (≥ 18 years of age) are presented in Table 1. The
proportion of children under 18 years was 47% of
patients receiving homeopathic compared to 35% receiv-
ing conventional treatment. Within this subpopulation
the average age and Body Mass Index (BMI) differed sig-
nificantly between both treatment groups. In adults, the
distribution of males and females, average age and BMI
differed significantly between the homeopathic and con-
ventional group.
As shown in Table 2, cough was the most frequently
reported chief complaint in children, followed by sore
throat and ear pain. In adults sore throat was the most fre-
quent, followed by cough and runny nose. The overall dis-
tribution of the five chief complaints in children was
comparable in both treatment groups, but differed signif-
icantly in adults (p = 0.0026, Chi-square test). The mean
severity score differed significantly at baseline for 2 out of
5 chief complaints, both in children and adults (Table 2).
With regard to the diagnosis of the chief complaints, in
children otitis media was most frequently diagnosed (H:
18.9%; C: 13.5%) followed by bronchitis (H: 16.7%; C:
10.7%) and laryngitis (H: 12.3%; C: 12.7%). In adults,
pharyngitis (H: 23.1%; C: 14.7%), bronchitis (H: 11.5%;
C: 17.1%) and tonsillitis (H: 13.9%; C: 8.9%) were most
frequently diagnosed. In adults, no significant differences
were observed with respect to concomitant medical prob-
lems (H: 34.2%; C: 36.6%) or concomitant medication
(H: 20.7%; C: 20.1%). In the homeopathic group 21.6%
of the children had concomitant medical problems versus
13.5% in conventional group (p = 0.0098; Fisher's exact
test). The proportion of children receiving concomitant
medication was higher in the homeopathic group (9.1%)
than in the conventional group (6.7%) as well but did not
reach a statistical significant level (p = 0.3098; Fisher's
exact test).
Medication
A total of 62 different homeopathic remedies were pre-
scribed primarily on an individual basis. The top 10
(Table 3) of the most frequently prescribed homeopathic
remedies included typical 'acute' remedies and accounted
for about 60% of the prescriptions. In the conventional
group 190 different medications were prescribed. Most of
them were antibiotics followed by nasal preparations and
analgesics (Table 3).
Treatment outcome
The primary outcome criterion, defined as the percentage
of patients with complete recovery or major improvement
after 14 days, was first calculated for the total patient pop-
ulation. The one-sided test of the full-set analysis showed
non-inferiority of homeopathic in comparison with con-
ventional treatment (H: 86.9%; C: 86.0%; p = 0.0003).
These results were confirmed by the analysis on the per-
protocol set (including all patients with data at day 14)
since similar response rates were obtained in both treat-
ment groups (H: 87.7%; C: 86.9%; p = 0.0019).
The response rates at various time points in children and
adults are shown in Figure 2. The primary outcome crite-
rion (response rate at day 14) in children was 88.5% after
homeopathic and 84.5% after conventional treatment. In
addition, response rates after 7 days (H: 68.8%; C: 64.3%)
and 28 days (H: 93.1%; C: 92.5%) did not differ between
both treatment groups either. In adults, the response rates
after 7 days (H: 71.2%; C: 68.8%), 14 days (H: 85.6%; C:
86.6%, LOCF) and 28 days (H: 93.9%; C: 95.9%; LOCF)
of treatment were not significantly different as well.
Since the majority of patients (> 84%) were fully recov-
ered or major improved after 14 days of treatment, it was
of relevance to look at outcome differences within the first
7 days. As shown in Figure 3, the percentage of children
experiencing a first improvement at different time points
within the first week of treatment was significantly higher
in the homeopathy group compared to the conventionalBMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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Patient flow-chart Figure 1
Patient flow-chart. * All patients who received at least one dose of investigational medication and having at least one follow-
up contact.
Homeopathy Conventional
All patients
No follow-up
Full-Set-Analysis*
Per protocol
2055
1577
576
80 147
1220 829
720
1116
540
Missing data
on day 14 180
857
281
6 No treatment
29 216 Excluded
patientsBMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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group (p = 0.0488). For adults, a similar significant differ-
ence in favour of homeopathy (p = 0.0001) was observed.
Additional analysis on the primary outcome criterion in
order to correct for demographic differences at baseline
was carried out (Figure 4). The unadjusted odds ratio
(OR) of the primary outcome criterion was 1.40 (0.89–
2.22) for children and 0.92 (0.63–1.34) for adults. In the
subgroup of children, adjustments for age, mean severity
and concomitant medical problems had little effect on the
OR. The unadjusted OR for the Body-Mass-Index was 1.92
(1.03–3.60) and the only one showing a significant differ-
ence in favour of homeopathy. Adjustment for BMI differ-
ences between both treatment groups at baseline
minimally reduced the OR to 1.89 (1.00–3.57). In adults,
individual adjustments for all variables had little to no
effect on the OR of the primary outcome criterion (Figure
4).
Another outcome measure was the occurrence of adverse
drug reactions. The percentage of children experiencing a
suspected adverse drug reaction was not significantly dif-
ferent in both groups (H: 2.0%; C: 2.4%, p  = 0.7838,
Fisher's exact test). In adults, the number of suspected
adverse drug reactions was significantly higher after con-
ventional than after homeopathic treatment (C: 7.6%; H:
3.1%; p = 0.0032, Fisher's exact test). Both in children and
adults, the suspected adverse drug reactions occurred pre-
dominantly in the body as a whole (upon homeopathic
treatment) or in the gastro-intestinal system (upon con-
ventional treatment).
In addition, patients' satisfaction with treatment and
healthcare provider was evaluated. Almost all patients in
both treatment groups were either satisfied or very satis-
fied with the treatment after 28 days (children: 95% H;
93% C, adults: 91% H; 95% C). A very high percentage of
Table 1: Demographic data
Children Homeopathy, n = 407 Conventional n = 252 p-value, if < 0.05
Male (%) 51.1 50.0
Female (%) 48.9 50.0
Age 6.6 ± 4.3 7.4 ± 4.7 = 0.0282a
BMI 16.6 ± 3.0 17.9 ± 3.7 = 0.0001a
Adults Homeopathy n = 445 Conventional n = 462 p-value, if < 0.05
Male (%) 24.0 32.3 = 0.0064b
Female (%) 76.0 67.7
Age 37.1 ± 12.5 39.6 ± 13.9 = 0.0124a
BMI 24.3 ± 4.8 25.0 ± 4.5 = 0.0031a
Smoking (%) 16.2 22.3
Full-set analysis values are either expressed as % of total or as mean ± SD, aWilcoxon rank-sum test, bFisher's exact test.
Table 2: Distribution and severity score of chief complaints at Day 0
Children Homeopathy n = 407 Conventional n = 252
Chief complaint (%) Severity score (%) Severity score p-valuea if < 0.05
Runny nose 9.8 1.1 ± 0.5 15.5 1.9 ± 0.7 = 0.0001
Sore throat 24.6 1.7 ± 0.6 23.0 1.6 ± 0.6
Ear pain 23.1 1.4 ± 0.6 21.0 1.0 ± 0.5 = 0.0002
Sinus pain 2.0 1.6 ± 0.4 3.6 1.7 ± 0.6
Cough 40.5 0.9 ± 0.5 36.9 1.1 ± 0.6
Adults Homeopathy n = 445 Conventional n = 462
Chief complaint % Severity score % Severity score p-valuea if < 0.05
Runny nose 15.1 1.5 ± 0.8 14.7 1.9 ± 0.7 = 0.0005
Sore throat 43.4 1.6 ± 0.7 32.3 1.5 ± 0.6
Ear pain 3.4 1.0 ± 0.3 5.4 1.3 ± 0.5
Sinus pain 8.3 1.5 ± 0.6 13.4 1.5 ± 0.6
Cough 29.9 1.0 ± 0.5 34.2 1.3 ± 0.5 = 0.0002
Full-set analysis values are either expressed as % of total or as mean ± SD. aWilcoxon rank-sum test, indicating the differences between severity 
scores (from 0 – not present to 4 – very severe) in the homeopathy and conventional group.BMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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children (H: 98%; C: 95%) and adults (H: 97%; C: 97%)
were either satisfied or very satisfied with the healthcare
provider.
Discussion
The overall outcome of the first phase of the IIPCOS study
[12] is confirmed in the present study on a larger group of
patients and a greater number of medical practices, show-
ing that homeopathic treatment is not inferior to conven-
tional treatment for the treatment of acute respiratory and
ear complaints. In IIPCOS-1 the response rate of homeo-
pathically treated patients was with 82.6% significantly
higher than in the conventional group. In IIPCOS-2 the
response to homeopathic treatment was with 86.9% even
higher, confirming the good effectiveness. However, no
difference was observed between both treatment groups.
This is due to a much higher response rate in the conven-
tional group in IIPCOS-2 of 86.0% compared to 68% in
IIPCOS-1. One difference between both studies is that in
IIPCOS-2, only patients from Europe were analysed since
those recruited at practices from the USA were excluded
due to protocol deviations. In IIPCOS-1, the majority of
patients included had their residence in the USA. How-
ever, despite these differences, the overall conclusion
from both studies can be drawn that homeopathy is not
inferior to conventional therapy. Due to the study design,
the findings of IIPCOS-1 and IIPCOS-2 do not provide
firm data on the comparative efficacy of homeopathic and
conventional treatment in acute diseases but rather under-
line the potential value of homeopathy in every day clini-
cal practice. Both studies reflect the situation in every day
homeopathic practice in an international setting with
average patients receiving the usual treatment of a home-
opathic doctor. Furthermore, patients were recruited on
the basis of chief complaints and related symptoms,
rather than on the clinical diagnoses. This symptomatic
approach coincides with the homeopathic nature of pre-
scription by treating each patient individually, based on
specific key symptoms and patient characteristics.
In IIPCOS-2, differences for various demographic param-
eters and symptom-related variables were found between
both groups. Thereby the profile of typical patients seek-
ing homeopathic therapy was confirmed [13,14], i.e. they
were more likely to be women, younger of age, less likely
to smoke and to have a lower BMI. The severity of symp-
toms at baseline was significantly different between treat-
ment groups as well. However the differences were small
and their clinical relevance is doubtful. Indeed regression
analysis had little effect on the primary outcome criterion,
showing that treatment effects were only minimally
affected by selection bias. Based on the unadjusted and
adjusted odds ratios of the primary outcome criterion it
appears that homeopathic treatment, in comparison to
conventional treatment, is more beneficial for children
than adults. This observation is in accordance with previ-
ous studies in which the improvements after homeo-
pathic treatment were greater in children than in adults
[11,13].
Another possible source of bias is that the outcome crite-
ria were assessed by the patients themselves. Since it was
not possible to blind patients for their treatment, poten-
tial reporting bias from patient's expectations may have
influenced the outcome. On the other hand, the patients'
reports were collected by independent external study col-
Table 3: The most frequently prescribed medications
Children Adults
Homeopathic treatment n = 407 % Homeopathic treatment n = 445 %
1. Belladonna 13.3 1. Hepar sulphuris 9.7
2. Pulsatilla 10.6 2. Belladonna 8.3
3. Hepar sulphuris 6.6 3. Bryonia alba 7.2
4. Mercurius solubilis 6.4 4. Lycopodium clavatum 7.2
5. Phosphorus 4.9 5. Kalium bichromicum 5.8
6. Bryonia alba 3.7 6. Mercurius solubilis 4.9
7. Calcarea carbonica 3.7 7. Allium cepa 4.5
8. Lycopodium clavatum 3.7 8. Phosphorus 3.4
9. Sulphur 3.7 9. Causticum 3.1
10. Phytolacca decandra 3.4 10. Gelsemium sempervirens 2.7
Conventional treatment n = 252 % Conventional treatment n = 462 %
1. Antibacterials 28.2 1. Antibacterials 39.4
2. Nasal preparations 22.6 2. Nasal preparations 15.2
3. Analgesics 12.7 3. Analgesics 9.5
4. Stomatological preparations 8.7 4. Cough/cold preparations 8.7
5. Anti-asthmatics 5.6 5. Stomatological preparations 5.2BMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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Response rates after 7, 14 and 28 days of treatment Figure 2
Response rates after 7, 14 and 28 days of treatment. Response rates (% of patients with complete recovery or major 
improvement) at 7, 14 and 28 days after treatment in children and adults. Full-set analysis with last observation carried forward 
(LOCF) at day 14 and 28. Children n = 659 (homeopathy, 407; conventional, 252) and adults n = 907 (homeopathy, 445; con-
ventional, 462).
Onset of improvement within the first week Figure 3
Onset of improvement within the first week. Onset of improvement within the first week of treatment (cumulative per-
centages of patients that experienced their first improvement). Children n = 659 (homeopathy, 407; conventional, 252) and 
adults n = 907 (homeopathy, 445; conventional, 462). Full-set analysis values with * p = 0.0448 for children and * p = 0.0001 for 
adults, using the Chi-square test on data points of the whole curve.
ł Homeopathy B ConventionalBMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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Main outcome measure – corrections for baseline Figure 4
Main outcome measure – corrections for baseline. Main outcome measure: response to treatment (complete recovery 
or major improvement) of full-set analysis data at day 14, unadjusted odds ratio's and adjusted odds ratio's for baseline differ-
ences with 95% confidence intervals. Between brackets: the number of responders in the homeopathy group and conventional 
group, respectively. Odds ratio above 1 indicates a better outcome upon homeopathic treatment.BMC Complementary and Alternative Medicine 2007, 7:7 http://www.biomedcentral.com/1472-6882/7/7
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laborators in order to minimize the influence of the
patient's relationship with their physician on the treat-
ment outcome. Although blinding of the external study
coordinators was foreseen in the protocol, it cannot be
ruled out that they received information from the patient
revealing the nature of their medication. Therefore, blind-
ing may not have been guaranteed in each case. Further-
more, it should be noted that at mixed centres, the choice
of treatment was made by the physicians and/or following
the patients' preference. The treatment decision may have
been influenced by the kind or severity of the symptoms
or the motivation and expectations of the patient.
Since acute respiratory and ear complaints are self-limit-
ing conditions, it can be argued that the chosen primary
outcome criterion after 14 days of treatment is not suffi-
ciently sensitive. Patients experiencing these acute com-
plaints may have undergone spontaneous recovery within
1 to 2 weeks. However, this outcome parameter was taken
to confirm and reproduce the results of IIPCOS-1 by using
a similar study design. Therefore other outcomes criteria
such as the response rate after 7 days of treatment have to
be considered more carefully. Moreover, the findings that
the percentage of patients experiencing a first improve-
ment within the first week was higher at all time points in
the homeopathy group than in the conventional group,
are at least supportive of the 14 days finding that home-
opathy is not inferior to conventional medicine.
Other observational studies on the comparability of
homeopathic treatment and conventional treatment of
upper respiratory tract infections (URTI) have shown pos-
itive outcomes for homeopathy [15,16]. Recently, the
value of homeopathic treatment for the prevention of
URTIs has been demonstrated in a controlled clinical trial
[17]. The consistent findings in IIPCOS-1 and IIPCOS-2
further contribute to the evidence that homeopathic treat-
ment plays a beneficial role in the primary care of
patients. Furthermore, the good tolerability of homeo-
pathic treatment of acute respiratory and ear complaints
was confirmed by the low number of patients that experi-
enced adverse drug reactions.
The major limitation of the present study is that patients
were not assigned randomly to their treatment group. The
majority of patients in the homeopathic group had a
strong treatment preference and consequently, they were
not willing to be randomized. A similar reluctance
towards randomisation has also been reported elsewhere
for patients seeking anthroposophic therapy [18]. These
results reveal a substantial limitation to the suitability of
performing large randomized controlled trials on the effi-
cacy of homeopathy in such a primary care setting.
Conclusion
This comparative cohort study, involving more than
1,500 patients in primary care practices of at least 6 differ-
ent European countries, demonstrates that homeopathic
treatment for acute respiratory and ear complaints was not
inferior to conventional treatment. Although no firm con-
clusions can be drawn about the efficacy of homeopathic
treatment, these results certainly contribute to the grow-
ing evidence that homeopathy is a safe and beneficial
treatment strategy for acute diseases in primary care set-
tings.
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